Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Jefferies Financial
JEF
CA Stock MarketDetailed Quotes
NURL Neural Therapeutics Inc
- 0.030
- -0.005-14.29%
15min DelayMarket Closed May 2 15:54 ET
2.66MMarket Cap-4.29P/E (TTM)
0.035High0.030Low39.11KVolume0.035Open0.035Pre Close1.35KTurnover0.05052wk High0.04%Turnover Ratio88.70MShares0.02052wk Low-0.007EPS TTM2.64MFloat Cap0.050Historical HighLossP/E (Static)87.96MShs Float0.020Historical Low-0.008EPS LYR14.29%Amplitude--Dividend TTM-3.33P/B1Lot Size--Div YieldTTM
About Neural Therapeutics Inc Company
Neural Therapeutics Inc is a wholly-owned subsidiary of High Fusion focused on ethnobotanical drug discovery and development company. Neural Therapeutics is focused on developing products and conducting research on the psychoactive cacti plants with the primary objective to find where the historical use in traditional medicine proves to be effective and capitalizing on the opportunities that can be applied in modern medical and natural health products markets.
Company Profile
SymbolNURL
Company NameNeural Therapeutics Inc
Founded2020
MarketCNQ
Fiscal Year Ends07-31
Address130 Adelaide Street Suite 3002
CityToronto
CountryCAN
Zip CodeM5H 3P5
Company Executives
No Data
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. Do you think Buffett was scooping up stocks during the recent dip? 2. In the face of market changes, do you prefer to stick
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts